| Ytd | 20.73% | |
| 1y | 36.33% |
| Open | 70.78 | Prev Close | 70.65 | Low | 70.56 | High | 71.00 | Mkt Cap | 11.06B |
| Vol | 11.82M | Avg Vol | 4.30M | EPS | 0.70 | P/E | 101.43 | Forward P/E | 34.54 |
| Beta | 1.36 | Short Ratio | 5.98 | Inst. Own | 118.36% | Dividend | 0.32 | Div Yield | 0.45 |
| Ex Div Date | 05-18 | Earning | 08-05 | 50-d Avg | 53.73 | 200-d Avg | 57.99 | 1yr Est | 68.00 |
MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Bio-Techne (NASDAQ: TECH) fo
BALA CYNWYD, Pa., June 30, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the followi
TD Cowen analyst Kyle Boucher downgrades Bio-Techne (NASDAQ:TECH) from Buy to Hold and raises the
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,
Are IRDM, TBPH, SYNA, TECH Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 2
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Citigroup analyst Patrick Donnelly downgrades Bio-Techne (NASDAQ:TECH) from Buy to Neutral and ra
ANTWERP, Belgium, 29 June 2026, 08:00 CET – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the company”) (NYSE:
NEW YORK, June 26, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Ass
Stephens & Co. analyst Steven Etoch downgrades Bio-Techne (NASDAQ:TECH) from Overweight to Eq
Bio-Techne Corporation (TECH) M&A Call Transcript
Baird analyst Catherine Schulte maintains Bio-Techne (NASDAQ:TECH) with a Neutral and raises the
Termination Fees The Company will be required to pay to Parent a termination fee equal to $230,455,0
On June 25, 2026, investors tracked deal progress as Bio-Techne shares responded to the proposed buy
Micron's blowout earnings powered memory and chip stocks higher, but the broad stock market rall
Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 2
Gainers Atlantic International (NASDAQ:ATLN) shares increased by 41.0% to $1.1 during Thursday'
MILWAUKEE, June 25, 2026 /PRNewswire/ -- Ademi LLP is investigating Bio-Techne (NASDAQ: TECH) for po
Dow Jones index gained 200 points; Acuity Inc (NYSE: AYI) reported better-than-expected financial re
Merck KGaA (OTC:MKKGY) (OTC:MKGAF) on Thursday agreed to acquire Bio-Techne Corporation (NASDAQ:TECH
Merck KGaA is acquiring Bio-Techne in an $11.3B all-cash deal to expand its life science, diagnostic
Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-m
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale
Bio-Techne stock jumps, with Germany's Merck KGaA buying the company at a 24% premium.
Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation
Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9
Merck KGaA has agreed to acquire biotech firm Bio-Techne Corp for $73 per share in cash, the Ge
Merck KGaA offered $73 a share in cash to buy Bio-Techne, representing a 24% premium to the U.S. lab
https://www.bloomberg.com/news/articles/2026-06-15/activist-investor-ananym-urges-bio-techne-to-cons
Piper Sandler analyst David Westenberg initiates coverage on Bio-Techne (NASDAQ:TECH) with a Neut
By combining R&D Systems MauriceFlex™ imaged capillary isoelectric focusing (icIEF) fractionatio